Pfizer Inc (PFE)
Pfizer Inc (PFE) carries a ŷRobot AI score of 68 out of 100. The model's fair value estimate is $31.83, 10.1% above the last close of $28.90. The chart signal reads Hold.
| Metric | PFE |
|---|---|
| AI score | 68 / 100 |
| Chart signal | Hold |
| Fair value estimate | $31.83 |
| Upside to fair value | 10.1% |
| Previous close | $28.90 |
| P/E | 40.54 |
| Price / sales | 2.76 |
| Market cap | $167.86B |
| EPS | 0.74 |
| Revenue growth | -15.6% |
| 1-year price change | 2.8% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about PFE
Is PFE overvalued or undervalued right now?
As of Nov 5, 2026, ŷRobot's fair-value model estimates Pfizer Inc (PFE) at $31.83 against a last close of $28.90, implying 10.1% upside to the model's estimate.
Is PFE's chart signal bullish or bearish?
The chart-signal model classifies PFE as Neutral as of Nov 13, 2026, with a signal score of -0.07 on a -1 to 1 scale.
What is PFE's ŷRobot AI score?
PFE scores 68 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is PFE stock expensive on P/E and P/S?
PFE trades at 40.5 times earnings and 2.8 times sales as of Nov 13, 2026.
What does PFE's seasonal forecast show?
ŷRobot's seasonal forecast curve for PFE reads +2.3% at 30 days, -0.8% at 90 days, and +2.8% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is PFE growing?
Pfizer Inc's revenue growth is -15.6% and free-cash-flow growth is +8.5% on the latest reported figures.
PFE chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.